If you’re looking for magic mushroom stocks to buy, you’re likely to be hunting for penny stocks right now.
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)
MindMed's recent financing has closed after being upsized all the way to CAD$34.5 million.
Psychedelic Stocks Pump Up The Volume
Psychedelic stocks are hitting new highs -- and doing so on record trading volumes. Feeding frenzies.
Modest price gains for gold, silver ahead of U.S. data
(Kitco News) - Gold and silver futures prices are seeing mild gains in early U.S. trading Thursday, ahead of some of U.S. economic data and on a corrective bounce from Wednesday’s losses.
Gold up moderately in follow-up to yesterday’s sell-off, Goldman and Citibank stick to their bullish forecasts for 2021
(USAGOLD – 12/8/2020) – Gold is up $5 this morning at $1847 reversing yesterday’s selloff that took the metal at one point to a low near $1825.
Psychedelic Quick Hits: Havn Life, MindMed, Mydecine
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) announced that it has completed its first commercial harvest of 20 kilograms of psilocybin mushrooms at its research and cultivation facility in Jamaica.
Plant Medicine Expands into New Realms
If the 2020 US election demonstrated anything, it's the growing appetite for natural medicines like cannabis and fungi.
Psychedelics: FDI’s next trip?
The past few months has seen a flurry of activity to do with psychedelics in North America: US cities and states have legalised psilocybin, and biotech psychedelic-assisted therapy companies have started to raise institutional capital and establish R&D centres overseas.
Medical Cannabis is Now Maine’s Most Lucrative Crop
Medical cannabis sales in Maine surpassed $221.8 million from January through November, making the crop the state’s most lucrative, outpacing potatoes, milk, hay, and wild blueberries, the Portland Press Herald reports.
Mind Cure (CSE: MCUR | OTC: MCURF) Moves into Psychedelic Assisted Therapy with British Columbia Location Offering Ketamine and Psilocybin Therapy
The company is set to open a therapeutic health and training center in Kelowna, British Columbia in May of 2021
Rotation Opportunity As Three Top Psychedelic Stocks Explode
Leading psychedelic stocks have gone ballistic in recent weeks. But where will investors find the NEXT multi-bagger opportunity?
New Jersey Considers Reducing Psilocybin Possession Penalties
Lawmakers in New Jersey’s Assembly Judiciary Committee have advanced a bill that would lower possession penalties for psilocybin mushrooms from a potential 5-year prison sentence to a maximum $1,000 fine and six months in jail.
